20 results
Key Characteristics of Old and New Potassium-Binding Agents

- Dr. Edgar V. Lerma https://twitter.com/edgarvlermamd

#Potassium #Binding #KBinders #Kayexelate
Agents - Dr. ... Kayexelate #Comparison #Table ... #Pharmacology # ... Patiromer #HyperKalemia ... #Nephrology #Agents
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... aspiration #Potassium #Binding ... medications #pharmacology ... #table #comparison
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
require phosphate binding ... agents since they ... restricted due to hypercalcemia ... Hyperphosphatemia #Dose #Dosing ... #Pharmacology #
Potassium Binders for Management of Hyperkalemia
 • SPS - Sodium polystyrene sulfonate
 • Patiromer (veltassa)
 •
of Hyperkalemia ... #Hyperkalemia # ... treatment #pharmacology ... #table #comparison ... #nephrology
A quick infographic describing some of the common reversal agents used by anesthesiologists, their mechanism of
mechanism of action, dosing ... #management #anesthesia ... anesthesiology #treatment ... anaesthesia and critical ... Pharmacology of
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
and Management ... Elimination (see Table ... : • K-Binding ... #Treatment #potassium ... #nephrology #K
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... Findings are summarised ... in Tables 5.2 and ... #Pharmacology # ... Effectiveness #Table
Rhabdomyolysis - Differential Diagnosis Framework and Management Summary

Causes of Rhabdomyolysis:
 • Trauma:
	- Immobilization
	- Crush injury
	- Compartment
Framework and Management ... Dermatomyositis Clinical ... per day until stable ... Differential #Diagnosis #Management ... #nephrology
Myasthenia Gravis - Summary
 • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
Diagnosis: • Based on clinical ... immunosuppressant agents ... - Improves clinical ... Gravis #diagnosis #management ... #neurology #treatment
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Tuberculosis #MDRTB #management ... #regimens #pharmacology ... #dosing #idsa #